Related Experiment Video
Updated: Jan 10, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Reduced Kidney Function and Left Atrial Dilatation as Predictors of Incident Atrial Fibrillation in Patients With
Yuriko Tsumaya1, Kenshi Hayashi2,3, Toyonobu Tsuda2
1Department of Clinical Laboratory Kanazawa University Hospital Kanazawa Japan.
Insights
Reduced kidney function and larger left atrial size predict new-onset atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM) patients. Early detection and monitoring are crucial for this high-risk group.
Area of Science:
- Cardiology
- Nephrology
- Clinical Research
Background:
- Atrial fibrillation (AF) is common in hypertrophic cardiomyopathy (HCM), increasing risks.
- Chronic kidney disease (CKD) is a cardiovascular risk factor, but its link to new-onset AF in HCM is unclear.
- Estimated glomerular filtration rate (eGFR) is a key indicator of kidney function.
Purpose of the Study:
- To determine the incidence of new-onset AF in HCM patients.
- To identify predictors of new-onset AF, focusing on kidney function and left atrial size.
Main Methods:
- 198 HCM patients without prior AF were analyzed.
- Kidney function (eGFR) and left atrial diameter (LAD) were assessed.
- Cox proportional hazards modeling identified predictors of AF.
Main Results:
- 17.7% of patients had impaired kidney function (eGFR < 60).
- Over 7.5 years, 21.7% developed new-onset AF (incidence 2.8/100 person-years).
- Reduced eGFR and increased LAD were independent predictors of AF.
Conclusions:
- Decreased kidney function and left atrial enlargement are linked to new-onset AF in HCM.
- HCM patients need closer monitoring for AF detection.
- Identifying these risk factors aids in managing AF risk in HCM.
Background:
Atrial fibrillation (AF), the most frequently occurring sustained arrhythmia in patients with hypertrophic cardiomyopathy (HCM), is linked to poor quality of life and increased thromboembolic risk. Chronic kidney disease (CKD) and reduced kidney function are known cardiovascular risk factors; however, their contributions to new-onset AF in patients with HCM remain unclear. Estimated glomerular filtration rate (eGFR) is a key marker for CKD management. This study aimed to elucidate the incidence of new-onset AF and to identify predictive factors in patients with HCM.
Methods:
We analyzed 198 patients with HCM (121 men; mean age, 58 ± 17 years) without prior AF. The incidence and predictors of new-onset AF were evaluated with a focus on kidney function and left atrial (LA) size. Cox proportional hazards modeling was used to assess the associations.
Results:
Impaired kidney function (eGFR < 60 mL/min/1.73 m2) was present in 35 patients (17.7%). Over a median follow-up of 7.52 years, 43 patients (21.7%) developed new-onset AF for an incidence rate of 2.8 per 100 person-years. The multivariate analysis identified reduced eGFR and increased LA diameter (LAD) as independent predictors of AF. Kaplan-Meier curves showed a significantly higher cumulative AF incidence among patients with an eGFR ≤ 76.1 mL/min/1.73 m2 or an LAD ≥ 48.0 mm.
Conclusions:
Decreased kidney function and LA dilatation were significantly associated with new-onset AF among patients with HCM. These findings suggest that this patient population requires closer monitoring for the early detection of AF.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease I: Introduction

